- Previous Close
258.65 - Open
262.75 - Bid 261.85 x 800
- Ask 262.20 x 800
- Day's Range
260.78 - 265.16 - 52 Week Range
213.31 - 527.18 - Volume
478,109 - Avg. Volume
2,088,201 - Market Cap (intraday)
31.508B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
18.43 - EPS (TTM)
14.20 - Earnings Date Oct 30, 2024
- Forward Dividend & Yield 3.54 (1.37%)
- Ex-Dividend Date Sep 30, 2024
- 1y Target Est
294.01
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
www.humana.comRecent News: HUM
View More
Related Videos: HUM
Performance Overview: HUM
Trailing total returns as of 10/24/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HUM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HUM
View MoreValuation Measures
Market Cap
31.14B
Enterprise Value
38.54B
Trailing P/E
18.21
Forward P/E
13.11
PEG Ratio (5yr expected)
1.04
Price/Sales (ttm)
0.28
Price/Book (mrq)
1.87
Enterprise Value/Revenue
0.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.53%
Return on Assets (ttm)
4.57%
Return on Equity (ttm)
10.15%
Revenue (ttm)
112.04B
Net Income Avi to Common (ttm)
1.71B
Diluted EPS (ttm)
14.20
Balance Sheet and Cash Flow
Total Cash (mrq)
22.93B
Total Debt/Equity (mrq)
79.33%
Levered Free Cash Flow (ttm)
-9.92B
Research Analysis: HUM
View MoreCompany Insights: HUM
HUM does not have Company Insights
Research Reports: HUM
View MoreCigna-Humana: Merger Talks Reportedly Back On, but We Still See Antitrust Risks
Humana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
RatingPrice TargetMorningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, antitrust issues curbing Big Tech M&A; a look at semiconductor industry; Hanesbrands' transformation has been overlooked; and EasyJet, Humana, and Repligen.
Humana: Shares Steeply Undervalued as Uncertainty Around Medicare Advantage Profit Trajectory Rises
Humana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
RatingPrice TargetHumana: Shares Steeply Undervalued as Uncertainty Around Medicare Advantage Profit Trajectory Rises
Humana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
RatingPrice Target